Building a new brand website to usher in a new chapter for a clinical-stage biotech
Industry:
Pharmaceuticals and Biotech
Offering:
Website development
Challenge
With Phase 1 clinical trials underway, SAb Biotherapeutics needed a refreshed brand narrative and visual identity to communicate its singular focus on developing therapies that have the potential to slow disease progression in adults with type 1 diabetes.
Approach
Discover
We interviewed 11 SAb Biotherapeutics leaders and external stakeholders to immerse ourselves in the company’s history and unearth their visions for the future. We also identified pain points associated with the company’s current visual identity, website and other external-facing materials
We conducted several interactive working sessions with executive team members to gain alignment on the company’s new brand narrative and visual identity
We audited SAb’s existing website to identify areas for improvement, benchmarked comparator companies and developed recommendations for updates to be made
Develop
- We developed several design options for SAb’s new brand identity, including a new name: SAB BIO
- In parallel, we developed recommendations for UX/UI and content updates to the website based on the company’s strategic pivot
Deploy
- We designed an updated website using the newly developed visual identity, brand narrative and tone of imagery and deployed updates the day before a key medical congress, generating positive feedback from executives, board members and stakeholders
Results
The new SAB BIO brand identity and refreshed website was announced on the eve of ADA, providing an updated public face for company representatives to showcase during their interactions with key stakeholders at this important medical meeting.
